A Study of HAIC Combined With Lenvatinib and Envolizumab in Potentially Resectable Hepatocellular Carcinoma
Clinical trial NCT06143579 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06143579
- Sponsor
- Sun Yat-sen University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-15
- Primary completion
- 2025-03-03
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.